However, in the context of viral infections, particularly HIV and by extension potentially HTLV-1, the strategy of BCL-2 inhibition may be more effective because viral persistence often relies heavily on BCL-2-mediated survival of infected cells [60]. The gene discussed is BCL2; the disease is viral infectious disease.